Fri.Jan 10, 2025

article thumbnail

FDA CDER director Patrizia Cavazzoni announces resignation

Pharmaceutical Technology

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

FDA 102
article thumbnail

Algorithm spots common sleep disorder linked to dementia

pharmaphorum

An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.

83
article thumbnail

PharmaVoice’s Crystal Ball: Industry shifts in R&D, policy and clinical trials

PharmaVoice

Coming changes that could impact pharma from drug development to launch.

Pharma 60
article thumbnail

Ouro makes debut with $120m for autoimmune disease TCEs

pharmaphorum

Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.

76
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System

MedCity News

Ouro Medicines drugs deplete disease-driving immune cells, allowing the immune system to reset with nave cells that dont attack the body. Monograph Capital founded the startup in partnership with GSK. The post Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System appeared first on MedCity News.

article thumbnail

CRISPR biotech Intellia cuts staff as it eyes 2027 launch

pharmaphorum

Eyeing a first commercial launch in 2027, Intellia is re-prioritising by cutting 27% of its workforce and shelving a lung disease candidate.

70

More Trending

article thumbnail

Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033

Pharmaceutical Technology

GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimers disease in 2033.

Leads 59
article thumbnail

Cavazzoni Retires as CDER Director

PharmaTech

Patrizia Cavazzoni, director of FDAs Center for Drug Evaluation and Research, has announced her retirement from the agency.

59
article thumbnail

Climb Bio enters licensing deal with Mabworks for CLYM116 development

Pharmaceutical Technology

Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biotech for developing and commercialising CLYM116.

59
article thumbnail

AstraZeneca’s PARP inhibitor newly recommended by NICE

European Pharmaceutical Review

The National Institute for Health and Care Excellence (NICE) has recommended Lynparza (olaparib) for adults with HER2-negative, locally advanced or metastatic breast cancer with germline BRCA1 or BRCA2 mutations after chemotherapy. NICEs final draft guidance on the poly-ADP ribose polymerase (PARP) inhibitor was based on positive results from the pivotal OlympiAD Phase III trial.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Coave Therapeutics raises $33m in funding to advance ALIGATER platform

Pharmaceutical Technology

Coave has raised 32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.

59
article thumbnail

Enhancing Patient Engagement Through Gamification in Healthcare

LEVO Health

In an increasingly digital healthcare landscape, keeping patients engaged has become a top priority for providers. One emerging strategy thats proving effective is gamification in healthcare. By integrating game-like elements into patient care, healthcare providers can drive better health outcomes, enhance patient loyalty, and improve overall satisfaction.

article thumbnail

Light Horse emerges with $62m and Novartis partnership worth up to $1bn

Pharmaceutical Technology

Light Horses CEO said the biotechs initial focus will be on high-value and historically challenging oncology targets.

59
article thumbnail

FDA Accepts Review of New GSK Prefilled Syringe Presentation

Pharmaceutical Commerce

The new form of the vaccine would remove the need for HCPs to combine the powder antigen and liquid adjuvant themselves prior to administering.

FDA 52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours

Pharmaceutical Technology

A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.

59
article thumbnail

Novo Nordisk, Valo Health Grow Partnership Centered Around Cardiometabolic Disease Therapies

Pharmaceutical Commerce

The collaboration is powered by the discovery and development of obesity, type 2 diabetes, and cardiovascular disease treatments.

52
article thumbnail

Newron and Myung In Pharm sign agreement for evenamide development

Pharmaceutical Technology

Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.

59
article thumbnail

FDA Grants Priority Review to Johnson & Johnson’s Nipocalimab for Generalized Myasthenia Gravis

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

The Evolution of Pharmaceutical Sample Distribution: From Push to Pull

Pharmaceutical Commerce

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, describes the progression of the sample distribution process.

article thumbnail

Additional Security Measures Taken for J.P. Morgan Healthcare Conference

PharmExec

San Francisco Police cancel time off requests to increase security at the J.P. Morgan Healthcare Conference after the recent murder of UnitedHealth Group CEO Brian Thompson.

article thumbnail

Koprosteine (Procysteine) : Multifunctional active

Pharmatutor

Koprosteine (Procysteine) : Multifunctional active admin Fri, 01/10/2025 - 16:29 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru Email : formulation_krc@kopresearchcentre.

52
article thumbnail

Blue Shield of California Issues Statement Regarding California Wildfires

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

World's largest proteomics trial launched by UK Biobank

pharmaphorum

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.

Pharma 51
article thumbnail

Havas Launches GLP-1 Focused Content Platform

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

As Wildfires Spread Across California, Pharmacists' Role in the Crisis Proves Essential

Pharmacy Times

As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.

38
article thumbnail

Amylyx Names New Chief Commercial Officer Ahead of GLP-1 Commercialization

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding

Pharmacy Times

Funding supports critical community pharmacy advocacy efforts to elevate and sustain the pharmacy profession.

26
article thumbnail

Potential blockbuster drugs to watch in 2025

European Pharmaceutical Review

Eleven medicines, covering key areas such as gene therapy, as well as drugs for obesity and oncology, are anticipated to attain blockbuster status or be therapeutic game-changers globally within five years to 2030, according to the 2025 edition of the Drugs to Watch report. These therapies are either newly launched or are set to be marketed in 2025, Clarivate explained.

article thumbnail

FDA Grants ALG-801 Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension

Pharmacy Times

ALG-801 could present new opportunities to improve treatment and management of patients with pulmonary arterial hypertension, a life-threatening condition.

article thumbnail

How Personalized Daily Rewards Close Care Gaps

MedCity News

When we meet members where they are whether its helping them buy groceries or find transportation to a doctors appointment were not just closing care gaps; were building trust. The post How Personalized Daily Rewards Close Care Gaps appeared first on MedCity News.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten